TITLE

Genetic Basis for Adverse Events after Smallpox Vaccination

AUTHOR(S)
Reif, David M.; McKinney, Brett A.; Motsinger, Alison A.; Chanock, Stephen J.; Edwards, Kathryn M.; Rock, Michael T.; Moore, Jason H.; Crowe Jr., James E.
PUB. DATE
July 2008
SOURCE
Journal of Infectious Diseases;7/1/2008, Vol. 198 Issue 1, p16
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Identifying genetic factors associated with the development of adverse events might allow screening before vaccinia virus administration. Two independent clinical trials of the smallpox vaccine (Aventis Pasteur) were conducted in healthy, vaccinia virus-naive adult volunteers. Volunteers were assessed repeatedly for local and systemic adverse events (AEs) associated with the receipt of vaccine and underwent genotyping for 1442 singlenucleotide polymorphisms (SNPs). In the first study, 36 SNPs in 26 genes were associated with systemic AEs (P ⩽.05); these 26 genes were tested in the second study. In the final analysis, 3 SNPs were consistently associated with AEs in both studies. The presence of a nonsynonymous SNP in the methylenetetrahydrofolate reductase (MTHFR)gene was associated with the risk ofAEin both trials (odds ratio [OR], 2.3 [95% confidence interval {CI}, 1.1-5.2] [P< .04] and OR, 4.1 [95% CI, 1.4 -11.4] [P<.01]). Two SNPs in the interferon regulatory factor-1 (IRF1) gene were associated with the risk of AE in both sample sets (OR, 3.2 [95% CI, 1.1-9.8] [P= .03] andOR, 3.0 [95% CI, 1.1- 8.3] [P = .03]). Genetic polymorphisms in genes expressing an enzyme previously associated with adverse reactions to a variety of pharmacologic agents (MTHFR) and an immunological transcription factor (IRF1) were associated with AEs after smallpox vaccination in 2 independent study samples.
ACCESSION #
32777915

 

Related Articles

  • Should you volunteer for the smallpox vaccine? Lorenzo, Penny // RN;Apr2003, Vol. 66 Issue 4, p69 

    Focuses on nurses' need for smallpox vaccine. Benefits and risks from smallpox vaccine; Coverage of lost time and wages.

  • Smallpox vaccine plan mired in concern over risks vs. benefits. Hitchens, Kathy // Drug Topics;2/17/2003, Vol. 147 Issue 4, p20 

    Reports issues concerning the risks and benefits of smallpox vaccination plan in the U.S. Shipment of the vaccine; Risks of adverse effects that can affect the effectiveness of live virus vaccine; Details on the liability protection given to individuals involved in the vaccination process.

  • Status of nation's smallpox vaccine reserve improves.  // American Journal of Health-System Pharmacy;5/1/2002, Vol. 59 Issue 9, p822 

    Discusses factors that contributed to the improvement in the potential national supply of smallpox vaccine in the U.S., as of March 2002. Evidence given by an online report by editors of the periodical 'New England Journal of Medicine' on the potency of vaccine stocks; Report on a previously...

  • Reply to Friedman. Kennedy, Jeffrey S.; Gurwith, Marc; Yokote, Hiroyuki; Greenberg, Richard N. // Journal of Infectious Diseases;Oct2012, Vol. 206 Issue 7, p1149 

    A letter to the editor is presented in response to a letter to the editor about the next generation of smallpox vaccines and poxviruses used as vectors in a 2012 issue.

  • The Immunogenetics of Smallpox Vaccination. Stanley Jr., Samuel L.; Frey,4, Sharon E.; Taillon-Miller, Patricia; Guo, Jianhua; Miller, Raymond D.; Koboldt, Daniel C.; Elashoff, Michael; Christensen, Ryan; Saccone, Nancy L.; Belshe, Robert B. // Journal of Infectious Diseases;7/15/2007, Vol. 196 Issue 2, p212 

    We hypothesized that individuals who develop fever after smallpox vaccination have genetically determined differences in their immune responses to vaccinia virus. We looked for an association between the development of fever and single-nucleotide polymorphisms (SNPs) in 19 candidate genes in 346...

  • Generalised vaccinia: case report.  // Reactions Weekly;5/29/2004, Issue 1003, p13 

    Discusses research being done on a woman who developed generalized vaccinia after receiving smallpox vaccine. Reference to a study by C. D. Kelly et al, published in the March 2004 issue of the "Journal of Clinical Microbiology"; Diseases developed after the patient have udergone smallpox...

  • Eradication of Smallpox.  // British Medical Journal;5/3/1975, Vol. 2 Issue 5965, p237 

    Focuses on the decreasing incidence of smallpox. Availability of freeze-dried vaccine in 1962; Organization of an eradication campaign by the World Health Organization in 1967; Presentation on the success of the campaign at a symposium at the Royal Society of Tropical Medicine and Hygiene in...

  • Smallpox vaccine: vaccinia DNA transmission risk?  // Reactions Weekly;5/6/2006, Issue 1100, p5 

    Provides information on research regarding smallpox vaccination. Percentage of patients who were vaccine-naive with a vaccinia strain; Conclusion drawn by the researchers with regards to vaccinia DNA transmission risk.

  • Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary Hepatocellular Carcinoma (HCC) in a Chinese population. Wei Cao; Zuo-Feng Zhang; Lin Cai; Qing-Wu Jiang; Nai-Chieh You; Binh Goldstein; Guo-Rong Wei; Chuan-Wei Chen; Qing-Yi Lu; Xue-Fu Zhou; Bao-Guo Ding; Jun Chang; Shun-Zhang Yu // Cancer Causes & Control;Aug2007, Vol. 18 Issue 6, p665 

    Abstract Objectives  Methylenetetrahydrofolate reductase (MTHFR), which is expressed in the liver, may be involved in both DNA methylation and DNA synthesis. It is also indicated as a potential risk factor of liver cancer in patients with chronic liver disease. To date, no study has been...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics